Certified by Founder Lodge
NewLimit
United States - South San Francisco, California
START UP
1 Disclosed Funding Rounds $40,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic me
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| May, 18 ,2023 | Series A | $40,000,000 | |
| May, 08 ,2025 | Series B | $130,000,000.00 |
Kleiner Perkins
Dimension
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
AIRRIVED | $6,100,000 | (Feb 4, 2026)
Derapi | $7,000,000 | (Feb 4, 2026)
Arbor(US) | $6,300,000 | (Feb 4, 2026)
Graici | $7,500,000 | (Feb 4, 2026)
enclaive | $4,849,418 | (Feb 4, 2026)
